Mazor Robotics Ltd. (TASE:MZOR, NASDAQ:MZOR) of Caesarea has promoted Christopher Prentice, SVP America & Global Marketing, to CEO of its United States subsidiary, Mazor Robotics, Inc. He will report directly to Ori Hadomi, CEO of the parent company, who made the following statement:
Chris’s contribution to our growth, from strategic planning to tactical execution, has been critical to our success. The US market represents our greatest growth opportunity and I am confident that Chris’s leadership, talent and proven capabilities will allow us to realize our objectives.
Prior to joining Mazor, Chris held leadership positions in marketing & sales at Ethicon Endo-Surgery, a Johnson & Johnson company, Intuitive Surgical, Inc., and served on the leadership team of Tampa General Hospital. Chris graduated from the United States Military Academy at West Point, has an MBA from Western New England University, and an MHA from the University of South Florida.
Mazor Robotics is a Caesarea-based company that develops semi-robotic, bone-mounted positioning systems for orthopedic procedures. Its flagship product, Renaissance, mounts to the patient and syncs with a surgical blueprint created prior to operation, allowing for accuracy and security in spinal and brain surgery. The systems have been successfully used in the placement of over 50,000 implants globally.
The company recently reported approval of its Renaissance system by the China Food and Drug Administration (CFDA). They also sold five systems in the third quarter of 2014, increasing the number of Renaissance systems installed in the United States to 44.
For more information, visit the company’s website at www.mazorrobotics.com.